Podcast

Scott Hamilton: When Fear Flips

Author(s):

Brielle Benyon

For this episode of the CURE Talks Cancer podcast, we spoke with Scott Hamilton, an Olympic gold medalist, cancer survivor and founder of the Scott Hamilton CARES Foundation

Receiving a cancer diagnosis can be terrifying—Olympic gold medalist Scott Hamilton knows that firsthand. However, after the shock wears off, it’s possible to use cancer as a motivation to do better in the world. That’s what Scott Hamilton did by starting the Scott Hamilton CARES foundation, which is dedicated to improving the future of cancer care.

In this week’s episode, we spoke with Hamilton about his personal bouts with testicular cancer and a brain tumor, as well as losing his mother to breast cancer. The former professional ice skater also touches upon why he wanted to be involved in CURE’s 2018 MPN Heroes event.

Related Videos
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine in the Department of Medicine at Beth Israel Deaconess Medical Center in Boston.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Richard “Rick" Winneker
Image of man with grey hair.
Image of woman with blonde hair.
Image of man with grey hair.
Image of man with grey hair.
Image of bald man in suit.
Related Content
"FDA" text.
January 28th 2025

FDA Approves Enhertu for HER2-Low and -Ultralow Breast Cancer

Darlene Dobkowski, MA
The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer with disease progression after endocrine therapy.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of blood-based test.
January 22nd 2025

Understanding the Concept of MRD for Patients With Cancer

Ryan Scott
Dr. Christopher Flowers discusses MRD testing in cancer care, why this is an important concept to understand and how it relates to recurrence in patients.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
"FDA" text.
January 17th 2025

FDA Approves Datroway for HR+, HER2- Breast Cancer

Alex Biese
Datroway has been approved for unresectable or metastatic HR+, HER2- breast cancer after endocrine therapy and chemotherapy.
Credit: Paul Archuleta - Getty Images
January 17th 2025

‘Nanny 911’ Star Deborah Finck Died, Danielle Fishel Completed Radiation and More

Alex Biese
From the death of a TikTok influencer to an update from a “Boy Meets World” star, here is this week’s news.